Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of this market.
The prostate cancer segment is expected to account for the second-largest share of the external beam radiotherapy market, by application, in 2018
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly